DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2252143/will-t-rowe-trow-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2252143 Apr 08, 2024 - T. Rowe (TROW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. 0

https://www.zacks.com/stock/news/2251984/analysts-estimate-m-t-bank-corporation-mtb-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2251984 Apr 08, 2024 - M&T Bank (MTB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 0

https://www.zacks.com/stock/news/2251993/the-zacks-analyst-blog-highlights-t-mobile-us-abbott-laboratories-palo-alto-networks-enterprise-products-partners-and-the-pnc-financial-services?cid=CS-ZC-FT-press_releases-2251993 Apr 08, 2024 - T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services are part of the Zacks top Analyst Blog. 0

https://seekingalpha.com/news/4087716-jj-wins-fda-nod-carvykti-label-expansion?source=feed_sector_healthcare Apr 06, 2024 - Johnson & Johnson (JNJ) has received FDA nod to expand the labeling for its CAR-T cell therapy Carvykti as an earlier line therapy for multiple myeloma. Read more here. 0

https://www.zacks.com/commentary/2251046/top-analyst-reports-for-t-mobile-us-abbott-laboratories-palo-alto-networks?cid=CS-ZC-FT-research_daily-2251046 Apr 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW). 0

https://seekingalpha.com/news/4087599-piper-downgrades-achilles-to-neutral-cites-latest-data?source=feed_sector_healthcare Apr 05, 2024 - Piper Sandler has downgraded Achilles (ACHL) to neutral in the wake of Phase 1/2 data from its CHIRON and THETIS studies for its precision T cell therapy. Read more here. 0

https://seekingalpha.com/news/4087581-bristol-myers-2seventy-bio-receive-fda-approval-for-abecma-to-treat-multiple-myeloma?source=feed_sector_healthcare Apr 05, 2024 - The CAR T therapy Abecma has been approved for adult patients with relapsed or refractory multiple myeloma after two or more prior lines of therapy. Read more here. 0

https://www.ocregister.com/2024/04/04/inglewood-settles-for-nearly-15-million-with-lapd-officer-hurt-in-mayors-2019-crash/ Apr 04, 2024 - Officer Michael Flynn and his motorcycle were flung into a water fountain near USC after a chain-reaction accident caused by Mayor James T. Butts Jr. 0

https://seekingalpha.com/article/4682126-bil-t-bills-are-good-these-funds-and-asset-classes-are-better?source=feed_tag_etf_portfolio_strategy Apr 04, 2024 - T-bills and BIL offer investors competitive yields with almost no risk and volatility, a solid combination. Find out my thoughts on the fund. 0

https://www.zacks.com/stock/news/2249211/comcast-s-cmcsa-xfinity-mobile-unveils-new-value-plans?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2249211 Apr 02, 2024 - Comcast's (CMCSA) Xfinity Mobile unveils new unlimited plans, offering more premium data and extra features compared with major telecom providers. 0